Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

被引:346
作者
Banasr, M. [2 ]
Chowdhury, G. M. I. [3 ,4 ]
Terwilliger, R. [2 ]
Newton, S. S. [2 ]
Duman, R. S. [2 ]
Behar, K. L. [3 ]
Sanacora, G. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, CNRU CMHC, New Haven, CT 06437 USA
[2] Yale Univ, Sch Med, Ribicoff Res Facil, New Haven, CT 06437 USA
[3] Yale Univ, Sch Med, Magnet Resonance Res Ctr, New Haven, CT 06437 USA
[4] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA
关键词
antidepressant; stress; glia; glutamate; glutamate transporter; metabolism; FIBRILLARY ACIDIC PROTEIN; MEDIAL PREFRONTAL CORTEX; MAJOR DEPRESSION; MOOD DISORDERS; FLUOXETINE TREATMENT; ENERGY-METABOLISM; CEREBRAL-CORTEX; NMDA RECEPTOR; NEURONAL SIZE; RAT;
D O I
10.1038/mp.2008.106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growing evidence indicates that glia pathology and amino-acid neurotransmitter system abnormalities contribute to the pathophysiology and possibly the pathogenesis of major depressive disorder. This study investigates changes in glial function occurring in the rat prefrontal cortex (PFC) after chronic unpredictable stress (CUS), a rodent model of depression. Furthermore, we analyzed the effects of riluzole, a Food and Drug Administration-approved drug for the treatment of amyotrophic laterosclerosis, known to modulate glutamate release and facilate glutamate uptake, on CUS-induced glial dysfunction and depressive-like behaviors. We provide the first experimental evidence that chronic stress impairs cortical glial function. Animals exposed to CUS and showing behavioral deficits in sucrose preference and active avoidance exhibited significant decreases in C-13-acetate metabolism reflecting glial cell metabolism, and glial fibrillary associated protein (GFAP) mRNA expression in the PFC. The cellular, metabolic and behavioral alterations induced by CUS were reversed and/or blocked by chronic treatment with the glutamate-modulating drug riluzole. The beneficial effects of riluzole on CUS-induced anhedonia and helplessness demonstrate the antidepressant action of riluzole in rodents. Riluzole treatment also reversed CUS-induced reductions in glial metabolism and GFAP mRNA expression. Our results are consistent with recent open-label clinical trials showing the drug's effect in mood and anxiety disorders. This study provides further validation of hypothesis that glial dysfunction and disrupted amino-acid neurotransmission contribute to the pathophysiology of depression and that modulation of glutamate metabolism, uptake and/or release represent viable targets for antidepressant drug development. Molecular Psychiatry (2010) 15, 501-511; doi:10.1038/mp.2008.106; published online 30 September 2008
引用
收藏
页码:501 / 511
页数:11
相关论文
共 51 条
  • [1] Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes
    Azbill, RD
    Mu, X
    Springer, JE
    [J]. BRAIN RESEARCH, 2000, 871 (02) : 175 - 180
  • [2] BANASR M, 2008, BIOL PSYCHIAT 0722
  • [3] Banasr Mounira, 2007, CNS & Neurological Disorders-Drug Targets, V6, P311, DOI 10.2174/187152707783220929
  • [4] Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat
    Banasr, Mounira
    Valentine, Gerald W.
    Li, Xiao-Yuan
    Gourley, Shannon L.
    Taylor, Jane R.
    Duman, Ronald S.
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 62 (05) : 496 - 504
  • [5] Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement
    Beart, P. M.
    O'Shea, R. D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (01) : 5 - 17
  • [6] Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression
    Choudary, PV
    Molnar, M
    Evans, SJ
    Tomita, H
    Li, JZ
    Vawter, MP
    Myers, RM
    Bunney, WE
    Akil, H
    Watson, SJ
    Jones, EG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) : 15653 - 15658
  • [7] Altered cerebral glucose and acetate metabolism in succinic semialdehyde dehydrogenase-deficient mice: evidence for glial dysfunction and reduced glutamate/glutamine cycling
    Chowdhury, G. M. I.
    Gupta, M.
    Gibson, K. M.
    Patel, A. B.
    Behar, K. L.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 103 (05) : 2077 - 2091
  • [8] Glutamatergic and GABAergic neurotransmitter cycling and energy metabolism in rat cerebral cortex during postnatal development
    Chowdhury, Golam M. I.
    Patel, Anant B.
    Mason, Graeme F.
    Rothman, Douglas L.
    Behar, Kevin L.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (12) : 1895 - 1907
  • [9] Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder
    Cotter, D
    Mackay, D
    Chana, G
    Beasley, C
    Landau, S
    Everall, IP
    [J]. CEREBRAL CORTEX, 2002, 12 (04) : 386 - 394
  • [10] Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder
    Cotter, D
    Mackay, D
    Landau, S
    Kerwin, R
    Everall, I
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (06) : 545 - 553